Market Tracker

09/30 5:16pm ET

Nymox Pharmaceutical Corp (NASDAQ:NYMX)

3.26
Delayed Data
As of 4:00pm ET
 +0.03 / +0.93%
Today’s Change
1.62
Today|||52-Week Range
5.79
-0.61%
Year-to-Date
No recent news for Nymox Pharmaceutical Corp.

Today’s Trading

Previous close3.23
Today’s open3.20
Day’s range3.20 - 3.38
Volume133,101
Average volume (3 months)1,052,031
Market cap$149.0M
Dividend yield--
Data as of 4:00pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)-269.23%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-6.38%
P/E ratioNM
Price/Sales44.43
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NBRVNabriva Therapeutics...+0.00+0.01%
DPRXDipexium Pharmaceuti...-0.07-0.48%
BDSIBioDelivery Sciences...-0.03-1.10%
GLYCGlycoMimetics Inc+0.43+6.40%
Data as of 4:00pm ET, 09/30/2016

Financials

Last reporting dateMarch 11, 2016
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$2.8M
Annual profit (last year)-$17.9M
Net profit margin-647.67%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Paul Averback
Chief Financial Officer &
Secretary
Erik Danielsen
Corporate headquarters
Saint-Laurent, Quă©bec

Forecasts